Drugs / MOB015
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01246518 Comparator | Dec 2010 → Oct 2012 | fungal infection of the toenail | Moberg Pharma AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MOB015 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01246518 ↗ |
| Route | Topical | “Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis” NCT01246518 ↗ |